EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021

Gong Feng, Giovanni Targher, Christopher D Byrne, Yusuf Yilmaz, Vincent Wai-Sun Wong, Cosmas Rinaldi Adithya Lesmana, Leon A Adams, Jerome Boursier, George Papatheodoridis, Mohamed El-Kassas, Nahum Méndez-Sánchez, Silvia Sookoian und 48 weitere

JHEP Reports · 2025-03 · 7 (3) · 101271

DOI: 10.1016/j.jhepr.2024.101271 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JHEP Reports, 2025-03. Verfasst von Gong Feng und 59 weiteren Autor:innen. Beteiligte Einrichtung: Xi'an Medical University, Xi'an, China. Die Arbeit wurde bisher 126-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Scientific Research Plan Projects of Shaanxi Education Department, National Key Research and Development Program of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background & Aims: This study used the Global Burden of Disease data (2010-2021) to analyze the rates and trends of point prevalence, annual incidence, and years lived with disability (YLDs) for metabolic dysfunction-associated steatotic liver disease (MASLD) in 204 countries.

Methods

Total numbers and age-standardized rates per 100,000 population for MASLD prevalence, annual incidence, and YLDs were compared across regions and countries by age, sex, and sociodemographic index (SDI). Smoothing spline models were used to evaluate the relationship between the burden of MASLD and SDI. Estimates were reported with uncertainty intervals (UI).

Results

Globally, in 2021, the age-standardized rates per 100,000 population of point prevalence of MASLD were 15,018.1 cases (95% UI 13,756.5-16,361.4), annual incidence rates were 608.5 cases (598.8-617.7), and YLDs were 0.5 (0.3-0.8) years. MASLD point prevalence was higher in men than women (15,731.4 vs. 14,310.6 cases per 100,000 population). Prevalence peaked at ages 45-49 for men and 50-54 for women. Kuwait (32,312.2 cases per 100,000 people; 95% UI: 29,947.1-34,839.0), Egypt (31,668.8 cases per 100,000 people; 95% UI: 29,272.5-34,224.7), and Qatar (31,327.5 cases per 100,000 people; 95% UI: 29,078.5-33,790.9) had the highest prevalence rates in 2021. The largest increases in age-standardized point prevalence estimates from 2010 to 2021 were in China (16.9%, 95% UI 14.7%-18.9%), Sudan (13.3%, 95% UI 9.8%-16.7%) and India (13.2%, 95% UI 12.0%-14.4%). MASLD incidence varied with SDI, peaking at moderate SDI levels.

Conclusions

MASLD is a global health concern, with the highest prevalence reported in Kuwait, Egypt, and Qatar. Raising awareness about risk factors and prevention is essential in every country, especially in China, Sudan and India, where disease incidence and prevalence are rapidly increasing. Impact and implications: This research provides a comprehensive analysis of the global burden of MASLD, highlighting its rising prevalence and incidence, particularly in countries with varying sociodemographic indices. The findings are significant for both clinicians and policymakers, as they offer critical insights into the regional disparities in MASLD burden, which can inform targeted prevention and intervention strategies. However, the study's reliance on modeling and available data suggests cautious interpretation, and further research is needed to validate these findings in clinical and real-world settings.

Schlagwörter

Stichwörter der Autor:innen

EpidemiologyMetabolic dysfunction-associated fatty liver diseaseMetabolic dysfunction-associated steatotic liver diseaseNon-alcoholic fatty liver disease

Autor:innen und Institutionen

  • Xi'an Medical University, Xi'an, China.
  • The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Department of Medicine, University of Verona, Verona, Italy.
  • Metabolic Diseases Research Unit, IRCSS Sacro Cuore - Don Calabria Hospital, Negrar di Valpolicella, Italy.
  • Southampton National Institute for Health and Care Research Biomedical Research Centre, University Hospital Southampton and University of Southampton, Southampton General Hospital, Southampton, UK.
  • Department of Gastroenterology, School of Medicine, Recep Tayyip Erdoğan University, Rize, Turkey.

Förderung

  • Scientific Research Plan Projects of Shaanxi Education Department
  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Key Science and Technology Program of Shaanxi Province
  • Natural Science Basic Research Program of Shaanxi Province

Zitieren

APA

Feng, G., Targher, G., Byrne, C. D., Yilmaz, Y., Wai-Sun Wong, V., Adithya Lesmana, C. R., Adams, L. A., Boursier, J., Papatheodoridis, G., El-Kassas, M., Méndez-Sánchez, N., Sookoian, S., Castera, L., Chan, W. K., Ye, F., Treeprasertsuk, S., Cortez-Pinto, H., Yu, H. H., Kim, W., …, & Debzi, N. (2025). Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021. JHEP Reports, 7(3), 101271. https://doi.org/10.1016/j.jhepr.2024.101271

Vancouver

Feng G, Targher G, Byrne CD, Yilmaz Y, Wai-Sun Wong V, Adithya Lesmana CR, et al. Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021. JHEP Reports. 2025;7(3):101271. doi:10.1016/j.jhepr.2024.101271

BibTeX
@article{Feng2025,
  author = {Feng, Gong and Targher, Giovanni and Byrne, Christopher D and Yilmaz, Yusuf and Wai-Sun Wong, Vincent and Adithya Lesmana, Cosmas Rinaldi and Adams, Leon A and Boursier, Jerome and Papatheodoridis, George and El-Kassas, Mohamed and Méndez-Sánchez, Nahum and Sookoian, Silvia and Castera, Laurent and Chan, Wah-Kheong and Ye, Feng and Treeprasertsuk, Sombat and Cortez-Pinto, Helena and Yu, Hon Ho and Kim, Won and Romero-Gómez, Manuel and Nakajima, Atsushi and Win, Khin Maung and Kim, Seung Up and Holleboom, Adriaan G and Sebastiani, Giada and Ocama, Ponsiano and Ryan, John D and Lupșor-Platon, Monica and Ghazinyan, Hasmik and Al-Mahtab, Mamun and Hamid, Saeed and Perera, Nilanka and Alswat, Khalid A and Pan, Qiuwei and Long, Michelle T and Isakov, Vasily and Mi, Man and Arrese, Marco and Sanyal, Arun J and Sarin, Shiv Kumar and Leite, Nathalie Carvalho and Valenti, Luca and Newsome, Philip N and Hagström, Hannes and Petta, Salvatore and Yki-Järvinen, Hannele and Schattenberg, Jörn M and Castellanos Fernández, Marlen I and Leclercq, Isabelle A and Aghayeva, Gulnara and Elzouki, Abdel-Naser and Tumi, Ali and Sharara, Ala I and Labidi, Asma and Sanai, Faisal M and Matar, Khaled and Al-Mattooq, Maen and Akroush, Maisam Waid and Benazzouz, Mustapha and Debzi, Nabil},
  title = {Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021},
  journal = {JHEP Reports},
  year = {2025},
  volume = {7},
  number = {3},
  pages = {101271},
  doi = {10.1016/j.jhepr.2024.101271}
}
Kostenlos starten →